Novartis is one of those companies that politicians and policymakers like to talk so much about. It makes real things. It employs real people. It pays real tax. The Swiss drugmaker has in the region of 700 Irish staff, ranging from high-level management to general administration workers. Accounts for its main Irish subsidiary, Novartis Ireland Limited, show it received revenues in 2019 of €221 million and made a pre-tax profit of €6.5 million. It made this money by supplying pharmaceutical products to the healthcare sector and providing business services to group and subsidiary companies. On any metric, the business is…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €100.

Subscribe

Cancel anytime.

Are you already a member? .